Herbas VPB

Print
EN | LT
LT - CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF CYSTITIS
EN - CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF CYSTITIS

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 38/17 (2006.01)
C07K 14/47 (2006.01)
A61K 48/00 (2006.01)
C07K 16/40 (2006.01)
C12N 15/00 (2006.01)
A61P 25/28 (2006.01)
A61P 3/10 (2006.01)
A61P 41/00 (2006.01)
A61P 13/12 (2006.01)
A61P 1/02 (2006.01)
A61P 3/04 (2006.01)
A61P 7/00 (2006.01)
A61P 7/04 (2006.01)
A61P 7/06 (2006.01)
A61P 9/12 (2006.01)
A61P 9/14 (2006.01)
A61P 17/00 (2006.01)
A61P 17/06 (2006.01)
A61P 17/10 (2006.01)
A61P 19/08 (2006.01)
European patent
(11) Number of the document 3160489
(13) Kind of document T
(96) European patent application number 15732533.3
Date of filing the European patent application 2015-06-26
(97) Date of publication of the European application 2017-05-03
(45) Date of publication and mention of the grant of the patent 2023-06-07
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/EP2015/001294
Date 2015-06-26
PCT application publication
(87) Number WO 2015/197194
Date 2015-12-30
Priority applications
(30) Number Date Country code
PCT/EP2014/001736 2014-06-26 WO
PCT/EP2014/002724 2014-10-08 WO
Inventors
(72)
COMBETTE, Jean-Marc , FR
DELOCHE, Catherine , CH
Grantee
(73) Xigen Inflammation Ltd. , Arch. Makariou III 195 Neocleous House, 3030 Limassol, CY
Title
(54) CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF CYSTITIS
  CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF CYSTITIS